Guidance

Offender healthcare settings and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in offender healthcare settings

Non-acute settings with healthcare input and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in non-acute settings with healthcare input

Semi-acute settings and transcribing

28 January 2025Consideration needs to be given to the risk factors particularly associated with transcribing in semi-acute settings

Choosing between oral vancomycin options

18 June 2025Organisations should choose suitable formulary options for oral vancomycin and mitigate risks. Several factors affect decision making.

Choosing between fidaxomicin options

18 June 2025Organisations should choose suitable fidaxomicin formulary options and mitigate risks. Several factors affect decision making.

Managing interactions with direct oral anticoagulants (DOACs)

5 January 2024Interactions with apixaban, dabigatran, edoxaban or rivaroxaban can result in increased risks of a bleed or thrombosis. We advise on management options.

MSATS – Safe use of valproate

28 February 2024Discussion of key current medication safety challenges within healthcare with a focus on the safe use of valproate; inspiring partnership across the system

Managing an intrathecal chemotherapy service

13 June 2025The intrathecal route is a high-risk route of administration. There are minimum requirements for providing intrathecal chemotherapy.

Choosing an injectable medicine for intrathecal administration

11 August 2022The intrathecal route is a high risk route of administration. It is essential to consider the properties of the medicinal product when assessing the risk

Preventing harm from incorrect vinca alkaloid administration

13 June 2025Vinca alkaloids can cause paralysis and death if given by the wrong route. Understand how to reduce the risk to patients.

SPS - Specialist Pharmacy Service

NHS